The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings

Trevor Bickford; Nicholas Kinder; Wade Arthur; Cole Wayant; Matt Vassar

doi:10.1016/j.chest.2020.10.073

The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings

Trevor Bickford, Nicholas Kinder, Wade Arthur, Cole Wayant, Matt Vassar

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2399-2401
Number of pages	3
Journal	Chest
Volume	159
Issue number	6
DOIs	https://doi.org/10.1016/j.chest.2020.10.073
State	Published - Jun 2021

Access to Document

10.1016/j.chest.2020.10.073

Cite this

@article{9bd12ecb8ff44d14a123847232c50c1e,

title = "The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings",

author = "Trevor Bickford and Nicholas Kinder and Wade Arthur and Cole Wayant and Matt Vassar",

year = "2021",

month = jun,

doi = "10.1016/j.chest.2020.10.073",

language = "English",

volume = "159",

pages = "2399--2401",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "6",

}

TY - JOUR

T1 - The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings

AU - Bickford, Trevor

AU - Kinder, Nicholas

AU - Arthur, Wade

AU - Wayant, Cole

AU - Vassar, Matt

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85103727062&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2020.10.073

DO - 10.1016/j.chest.2020.10.073

M3 - Article

C2 - 33171160

AN - SCOPUS:85103727062

SN - 0012-3692

VL - 159

SP - 2399

EP - 2401

JO - Chest

JF - Chest

IS - 6

ER -

The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings

Access to Document

Other files and links

Cite this